Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. (2017)
Attributed to:
University of Birmingham MRC Proximity to Discovery: Open Innovation Through Local
Integration
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/cei.12940
PubMed Identifier: 28176332
Publication URI: http://europepmc.org/abstract/MED/28176332
Type: Journal Article/Review
Volume: 188
Parent Publication: Clinical and experimental immunology
Issue: 3
ISSN: 0009-9104